Publication Topic

Doepker C, Franzen A, Brorby G, Brown L, Choksi N, East A, Wikoff D. 2026. Smoke flavoring—A case study demonstrating the value of using benefit-risk analysis for foods (BRAFO) to provide transparency for risk management decisions. Regul Toxicol Pharmacol 167(May):106033; doi: 10.1016/j.yrtph.2026.106033. PMID: 41577161.

Lea IA, Buerger AN, Vincent MJ,…, Choksi NY, Schaefer H, Britt J, Fitch S, Haws L, Borghoff SJ. 2026. Evaluating the potential carcinogenic hazard of diisononyl phthalate in humans via systematic integration of human, animal cancer studies, and mechanistic data. Curr Res Toxicol 10(Apr 30):100295; doi: 10.1016/j.crtox.2026.100295.

Buerger AN, Thompson CM, Heintz MM, Maberti S, Palermo CM, Haws LC. 2026. Application of quantitative and qualitative uncertainty assessment risk management decision-making: A case study with diisononyl phthalate. Food Chem Toxicol 116110; doi: 10.1016/j.fct.2026116110. Online ahead of print April 25. PMID: 42035978.

Massarsky A, Evans VJB, Fung ES, Yang LGL, Rogers KL, Buerger AN, Maier A, Reichard JF. A framework for assessing the safety of degraded pharmaceuticals for long-duration space missions—Part II: Framework application in four case studies. Crit Rev Toxicol; doi: 10.1080/10408444.2026.2633422. Online ahead of print April 16. PMID: 41988975.

Thompson CM, Heintz MM, Rogers SI, Vincent MJ, Haws LC. 2026. Integration of mechanistic and repeat dose toxicity data in the derivation of an oral reference dose for HFPO-DA. Toxicol Sci April 10:kfag045; doi: 10.1093/toxsci/kfag045. Online ahead of print April 10^th. PMID: 41968070.

Massarsky A, Evans VJB, Fung ES, Yang LGL, Rogers KL, Buerger AN, Maier A, Reichard JF. A framework for assessing the safety of degraded pharmaceuticals that will be required for long-duration space missions—Part I: Framework development. Crit Rev Toxicol; doi: 10.1080/10408444.2025.2533943. Online ahead of print April 9. PMID: 4195218.

Bond G, Becker RA, Rish W, Ryman JP, Verwiel AH. 2026. Cumulative impact assessment within vulnerable communities: Challenges, opportunities and path forward. J Toxicol Regul Pol. Accepted, April 7, 2026.

Vincent M, Wheeler M, Schaefer H, Rhoden J, Fitch S, Wikoff D. Quantitative bias assessment to facilitate assessment of (un)certainty in observational data evaluating acetaminophen use and liver cancer. Abstract 4279, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Shobair M, Allen D, Ballone I, Brull M, Burbank M, Choksi N, Fitch S, Irizar A, et al. A machine-learning approach for the development of a knowledgebase to identify systemic toxicity mechanistic targets and evaluate biological space coverage. Abstract 5161, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Patlewicz G, Mihalchik A, Thompson CM, East A, Borghoff S. Investigating the feasibility of deriving a new environmentally relevant Thresholds of Toxicological Concern (TTCs) from estimated human equivalent benchmark dose (eBMD_HED) values. Abstract 4013, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Killius A, Wheeler M, Covell L, Price S, Finley B. 2026. Derivation of provisional chronic oral toxicity values (PCOTV) for novel short-chain PFAS congeners. J Appl Toxicol; doi: 10.1002/jat.70156. Online ahead of print March 12. PMID: 41814952.

Kennedy SB, Antonio Vital AL, Kukkola A, Miller E, Yeh A, Coffin S, Ahmed TK, Bertrand L, et al. 2026. Trends in quality and risk assessment applicability of microplastic ecotoxicity studies. J Haz Mat Adv 21(Feb):100942; doi: 10.1016/j.hazadv.2025.100942.

Coffin S, Bertrand L, Ahmed KT, de Souza Leite L, Cowger W, Sina M,… Kennedy S, et al. 2026. A probabilistic risk framework for microplastics integrating uncertainty across toxicological and environmental variability: Development and application to marine and freshwater ecosystems. J Haz Mat 503(Feb 1):141021; doi: 10.1016/j.hazmat.2025.141021. PMID: 41548305.

Wheeler M, Wikoff D, Vincent M. Annealed Bayesian bias assessment in epidemiological studies. Session M2-H, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Verwiel A, Rish W. Importance of integrating cumulative chemical exposures into cumulative impact assessment for vulnerable communities. Session T1-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Hoffman S, Wikoff D, Brown L, Wheeler M. Advancing quantitative uncertainty assessment in next generation risk assessment. Session T2-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

Heintz MM, Kennedy SB, Brown L, Fender CL, Hecker M, Hughes SA, Naile J, DeLeo P. Toxicogenomics in ecological risk assessment: Current landscape, research gaps and recommendations to increase confidence across sectors. Abstract 1.02.T-01, SETAC North America 46^th Annual Meeting, Portland, OR, November 2025.

Bare JL, Fender CL, Torres C, Panko J. Assessing environmental monitoring data quality and reliability in TSCA risk evaluations using 4-tert-octylphenol as a case study. Abstract 7.05.P-Mo-116, SETAC North America 46^th Annual Meeting, Portland, OR, November 2025.

Proctor D, Jiang X, Reichert H, Thompson C. 2025. Why rat oral cavity tumors should not be the basis of quantitative cancer risk assessment for oral exposure to hexavalent chromium. Toxicol Sci 208(1):42-47; doi: 10.1093/toxsci/kfaf112. PMID: 40795394.

Allen BC, Vincent MJ, Lipworth L, Panko JM, Suh M, Jiang X, Mumma MT, Proctor DM. 2025. Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohorts. J Occup Environ Hyg 22(10):821-835; doi: 10.1080/15459624.2025.2502491. PMID: 40435461.